- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Evolocumab – July 2018
Evolocumab: Injection 140 mg in 1 ml single use pre-filled pen; Injection 420 mg in 3.5 ml single us
Last updated
26 October 2018